- Home
- Publications
- Publication Search
- Publication Details
Title
Therapies on the Horizon for Diabetic Kidney Disease
Authors
Keywords
Diabetic nephropathy, Bardoxolone, TGF-β, JAK/STAT
Journal
Current Diabetes Reports
Volume 15, Issue 12, Pages -
Publisher
Springer Nature
Online
2015-10-13
DOI
10.1007/s11892-015-0685-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema
- (2015) NEW ENGLAND JOURNAL OF MEDICINE
- Mechanisms Contributing to Adverse Cardiovascular Events in Patients with Type 2 Diabetes Mellitus and Stage 4 Chronic Kidney Disease Treated with Bardoxolone Methyl
- (2014) Melanie P. Chin et al. AMERICAN JOURNAL OF NEPHROLOGY
- Non-Proteinuric Diabetic Nephropathy
- (2014) Varun Chawla et al. Current Diabetes Reports
- Effect of Pentoxifylline on Renal Function and Urinary Albumin Excretion in Patients with Diabetic Kidney Disease: The PREDIAN Trial
- (2014) J. F. Navarro-Gonzalez et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- NADPH Oxidase 1 Plays a Key Role in Diabetes Mellitus–Accelerated Atherosclerosis
- (2013) Stephen P. Gray et al. CIRCULATION
- Uric Acid Lowering to Prevent Kidney Function Loss in Diabetes: The Preventing Early Renal Function Loss (PERL) Allopurinol Study
- (2013) David M. Maahs et al. Current Diabetes Reports
- The Nrf2 pathway in the progression of renal disease
- (2013) C. Zoja et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Combined Angiotensin Inhibition for the Treatment of Diabetic Nephropathy
- (2013) Linda F. Fried et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mechanisms of Diabetic Complications
- (2013) Josephine M. Forbes et al. PHYSIOLOGICAL REVIEWS
- The synthetic triterpenoid RTA dh404 (CDDO-dhTFEA) restores Nrf2 activity and attenuates oxidative stress, inflammation, and fibrosis in rats with chronic kidney disease
- (2013) Mohammad A. Aminzadeh et al. XENOBIOTICA
- KDOQI Clinical Practice Guideline for Diabetes and CKD: 2012 Update
- (2012) AMERICAN JOURNAL OF KIDNEY DISEASES
- Cardiorenal End Points in a Trial of Aliskiren for Type 2 Diabetes
- (2012) Hans-Henrik Parving et al. NEW ENGLAND JOURNAL OF MEDICINE
- Orchestral actions of angiopoietin-1 in vascular regeneration
- (2012) Gou Young Koh TRENDS IN MOLECULAR MEDICINE
- Notice
- (2012) Kidney International Supplements
- Sulodexide for Kidney Protection in Type 2 Diabetes Patients With Microalbuminuria: A Randomized Controlled Trial
- (2011) Edmund J. Lewis et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Antiproteinuric Effect of Chemokine C-C Motif Ligand 2 Inhibition in Subjects with Acute Proliferative Lupus Nephritis
- (2011) Alessandro Ble et al. AMERICAN JOURNAL OF NEPHROLOGY
- Serum Uric Acid Levels and Incident Chronic Kidney Disease in Patients With Type 2 Diabetes and Preserved Kidney Function
- (2011) G. Zoppini et al. DIABETES CARE
- Temporal Trends in the Prevalence of Diabetic Kidney Disease in the United States
- (2011) Ian H. de Boer JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Angiopoietin-1 is essential in mouse vasculature during development and in response to injury
- (2011) Marie Jeansson et al. JOURNAL OF CLINICAL INVESTIGATION
- Addition of Atrasentan to Renin-Angiotensin System Blockade Reduces Albuminuria in Diabetic Nephropathy
- (2011) D. E. Kohan et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Sulodexide Fails to Demonstrate Renoprotection in Overt Type 2 Diabetic Nephropathy
- (2011) D. K. Packham et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Pirfenidone for Diabetic Nephropathy
- (2011) K. Sharma et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Bardoxolone Methyl and Kidney Function in CKD with Type 2 Diabetes
- (2011) Pablo E. Pergola et al. NEW ENGLAND JOURNAL OF MEDICINE
- Oxidative Stress and Diabetic Complications
- (2010) Ferdinando Giacco et al. CIRCULATION RESEARCH
- Effect of Allopurinol in Chronic Kidney Disease Progression and Cardiovascular Risk
- (2010) M. Goicoechea et al. Clinical Journal of the American Society of Nephrology
- Suppressors of Cytokine Signaling Abrogate Diabetic Nephropathy
- (2010) G. Ortiz-Munoz et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Avosentan for Overt Diabetic Nephropathy
- (2010) J. F.E. Mann et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial
- (2010) Dick de Zeeuw et al. LANCET
- Effect of Pentoxifylline on GFR Decline in CKD: A Pilot, Double-Blind, Randomized, Placebo-Controlled Trial
- (2009) Robert M. Perkins et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Avosentan Reduces Albumin Excretion in Diabetics with Macroalbuminuria
- (2009) R. R. Wenzel et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- The Effect of Pentoxifylline on Proteinuria in Diabetic Kidney Disease: A Meta-analysis
- (2008) Brendan B. McCormick et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial
- (2008) Johannes FE Mann et al. LANCET
- Co-regulation of Gremlin and Notch signalling in diabetic nephropathy
- (2007) David W. Walsh et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started